PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Government to invest £16m in ‘life-saving’ medical advances

The Government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, including improved diagnosis and treatment for cancer and heart disease.

13 ‘precision medicine’ projects from UK-based small or medium-sized enterprises (SMEs) will get a share of the money, so they can use a combination of information about a patient’s genes, proteins and environment, and medical images, which will then be used to do things such as explore cell-based therapy to treat a currently incurable form of lung cancer, and develop a blood test for early detection of brain cancer.

“From the discovery of penicillin, to the invention of the hip replacement operation, the UK has a rich history of driving crucial medical breakthrough,” explained business secretary, Greg Clark.

He went on to say that “Now UK firms are on the precipice of ground-breaking advances using ‘precision medicine’ technologies – meaning early diagnosis and better treatment for devastating diseases including cancer and heart disease.

“Through our modern Industrial Strategy, we are delivering the biggest ever boost to R&D funding in UK history. This new £16m investment in the UK’s brightest medical gamechangers will propel crucial research from laboratory to market, ensuring the population can reap the rewards of these life-saving advances, sooner rather than later.”

This funding is available are part of the Government’s modern Industrial Strategy, which is keeping the UK at the forefront of development disruptive new technologies – as well as making the UK one of the “most exciting places to start a business for budding entrepreneurs.”

Alongside the funding, a competition has now opened allowing medical companies to be in with the chance to win a slice of £22m to develop digital pathology technologies – which could help medical professionals diagnose diseases.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026